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Abstract
Introduction: Smoking cessation support is increasingly delivered in primary care by auxiliary 
healthcare workers in place of healthcare professionals. However, it is unknown whether this shift 
might affect the quality and impact of the support delivered.
Methods: Data from the iQuit in Practice randomized control trial of cessation support in General 
Practice was used (N = 602). Analyses assessed whether cessation advisor type (nurse or health-
care assistant [HCA]) was associated with abstinence (primary outcome: self-reported 2-week point 
prevalence abstinence at 8 weeks follow-up), the advice delivered during the initial consultation, 
pharmacotherapies prescribed, patient satisfaction, initial consultation length, and the number 
and type of interim contacts.
Results: There were no statistically significant differences in abstinence for support deliv-
ered by HCAs versus nurses at 8 weeks (HCAs 42.8%, nurses 42.6%; unadjusted odds ratio 
[OR] = 1.01, 95% confidence interval [CI] = 0.73 to 1.40), or at 4 weeks or 6 months follow-up. 
There were no statistically significant differences in advice delivered, the types of pharma-
cotherapies prescribed or patient satisfaction. Compared with nurses, HCA consultations 
were longer on average (HCAs 23.6 minutes, nurses 20.8 minutes; P = .002) and they under-
took more interim contacts (HCAs median 2, nurses median 1; P < .001), with contact more 
likely to be face-to-face than phone call (HCAs 91.2%, nurses 70.9%; OR = 4.23, 95% CI = 2.86 
to 6.26).
Conclusions: HCAs appear equally effective as nurses in supporting smoking cessation, although 
they do this with greater patient contact. Using auxiliary practitioners to deliver cessation support 
could free up nurse time and reduce costs.
Implications: This study found that primary care patients receiving smoking cessation support 
from auxiliary healthcare workers were just as likely to be abstinent up to 6  months later as 
those patients seen by nurses. While the auxiliary healthcare workers achieved this with slightly 
increased patient contact time, the advice delivered, pharmacotherapies provided and patient sat-
isfaction were similar to that of nurses. Expanding the auxiliary healthcare worker role to include 
smoking cessation support could increase role satisfaction and reduce the costs of cessation sup-
port delivery in primary care.
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Introduction
The involvement of a health professional in an attempt to quit smok-
ing is associated with increased likelihood of success.1–3 In the English 
Stop Smoking Services there is a broad division between specialist 
Smoking Cessation Advisors (SCAs), where smoking cessation is their 
main role, and community SCAs such as nurses for whom it is only 
part of their role. Several studies show that specialist SCAs produce 
higher quit rates in the patients they see compared with community 
SCAs.4,5 Furthermore, Brose et al.6 found differences in smokers’ car-
bon monoxide (CO) validated short-term (4-week) abstinence rates 
depending on which specialist SCA they saw, with individual success 
rates differing widely. However, beyond the division of specialist ver-
sus community SCA there are few studies looking at the effectiveness 
of specific types of community SCA in comparison with each other.
Primary care is the setting providing support to the highest num-
ber of smokers in the National Health Service (NHS) in England, 
with 227 624 smokers seen in 2013–2014.7 While community SCAs 
in primary care have traditionally been nurses, healthcare assistants 
(HCAs) are increasingly being trained in the role and delivering ces-
sation support. HCAs perform the role of a nursing auxiliary under 
the guidance of a qualified nurse. Compared to nurses, their qualifi-
cation requirement and salary is lower. Although there is not an exact 
role specification, HCAs generally carry out more basic elements of 
the nurse role including tasks such as blood pressure checks, height 
and weight measurements, simple dressing etc. A review of a Stop 
Smoking Service database in 2011 found that there were around half 
as many HCAs as nurses supporting smoking cessation treatment 
episodes in England (5604 compared with 13 095).8
The small number of previous studies examining differences 
between nursing auxiliaries and nurses in supporting smoking cessa-
tion have yielded mixed findings. Katz et al.9 carried out a secondary 
analysis of trial data and found no difference between medical assis-
tants’ and licensed practical nurses’ performance of smoking cessa-
tion activities compared with registered nurses (asking about smoking, 
assessing willingness to quit, advising quitting or assessing quitting). 
In terms of abstinence, Hiscock et al.8 analyzed quit attempts from a 
database of English Stop Smoking Services and found that patients 
who saw HCAs had higher success rates than those who saw nurses 
(odds ratio [OR] = 1.27; 95% confidence interval [CI] = 1.10 to 1.46). 
Although this study did not include any process measures, the authors 
speculated that this difference might have been because HCAs were 
able to spend more time with clients and may have been able to build 
rapport more effectively if they were from the same communities. 
Both previous studies have limitations, including an absence of the 
patients’ perspective on the receipt of the smoking cessation interven-
tion, the frequency and type of follow-up consultations and being lim-
ited to short-term smoking outcome measures.
The current study uses longitudinal data to look in detail at dif-
ferences in the delivery and receipt of smoking cessation treatment 
and short and long term smoking abstinence rates between the two 
main types of community SCAs in England: practice nurses and 
HCAs. The study used data from both SCAs and patients.
Methods
Design
This study uses data from the iQuit in Practice trial (iQIP) in an 
observational cohort design. iQIP is a two parallel group rand-
omized control trial with 1:1 allocation comparing usual care (con-
trol) with usual care plus the iQuit system (intervention) among 
smokers who attended their local General Practice (GP) surgery for 
smoking cessation support. Patients in both groups received an ini-
tial consultation after which their cessation advisor completed the 
first part of an online smoking related questionnaire on their behalf. 
Patients were then randomized by computer to either the control 
group, who were then informed their consultation had ended, or the 
intervention group who completed the second part of the question-
naire focusing on tailoring variables and then given the intervention. 
The intervention consisted of a program generated cessation advice 
report tailored to the smoker handed to them by their cessation advi-
sor and a 3-month program of automated tailored text messages sent 
to the smoker’s mobile phone. For more details see elsewhere.10,11 
Randomization was stratified by SCA to ensure that SCAs saw 
roughly equal numbers of intervention and control participants.
Sample
GPs in the East of England with at least one SCA (a primary care 
nurse or HCA) trained to give “level 2” smoking cessation advice 
according to the English Department of Health guidance12 with 
internet and printer access from their consultation room(s) were 
eligible. One hundred eighteen practices were contacted directly by 
the researchers between September 2009 and March 2011. Of the 
104 eligible practices approached, 32 participated (30.8%). Mean 
list size for participating practices was 10 538 (SD = 3638). A dep-
rivation measure, which combines 37 indicators of deprivation into 
a summary score (Index of Multiple Deprivation: IMD),13 indicated 
that eight practices were in the top 50% of deprived small geograph-
ical areas in England (Lower Super Output Areas; mean IMD score 
for study practices 13.7; range 3.0–27.7; SD = 7.0).
Patients were eligible for inclusion if they met the following crite-
ria: current smoker (usually smokes at least one cigarette a day, has 
smoked in the 7 days prior to randomization); able to read English 
and provide written informed consent; willing to set a quit date 
within 14 days after randomization; aged 18–75 years; has a mobile 
phone and is familiar with sending and receiving text messages; not 
enrolled in another formal smoking cessation study or program; and 
not using smoking cessation medications at randomization date. 
Participants were primarily recruited opportunistically, through 
self-referral or referred by a health professional, to receive smoking 
cessation advice. Practices were also encouraged to post study infor-
mation to a random selection of patients identified as smokers from 
their practice database. See study protocol for further information.11
Data Collection
Baseline data was collected from participants by SCAs at the ini-
tial consultation using a case report form and the online question-
naire. All participants were followed-up by an SCA 4 weeks after 
their quit date, as per usual care, and by postal questionnaire from 
the study centre at 8 weeks and 6  months after randomization. 
Nonresponders to the postal questionnaire were contacted by tel-
ephone by a researcher and given a choice of returning the ques-
tionnaire by post or completing it over the telephone. Participants 
unwilling to complete the full questionnaire were asked to complete 
the smoking outcomes questions only. Up to six attempts were made 
to contact participants by telephone at each follow-up.
Outcome Measures
Smoking Outcomes
The primary outcome measure used was self-reported 2-week point 
prevalence abstinence at the 8-week follow-up. This was chosen 
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over the 4-week follow-up outcome measure because the research 
team had control over the outcome definition and quality of data 
collection. The 8-week follow-up resulted in a higher response rate 
(506/602, 84.1%) compared with the 4-week SCA-led follow-up 
(421/602, 69.9%).
Two secondary smoking outcome measures were used: (1) 
CO-verified 2-week point prevalence abstinence at 4 weeks follow-
ing the quit date, recorded by the SCA. The English Department of 
Health defines a CO verified 4-week quitter as “a treated smoker 
whose CO reading is assessed 28 days from their quit date (−3 or 
+14 days) and whose CO reading is less than 10 parts per million.”14; 
(2) Self-reported 6-month prolonged abstinence at 6 months follow-
up after randomization.
Measurements of CO were recorded at the baseline consultation 
as well as at 4 weeks after a patient’s quit date using a calibrated 
Smokerlyser (Bedfont) CO monitor.
Cessation Support Delivered and Received
Five types of measures of cessation support were used:
1. The time taken for the consultation, measured by the SCAs from 
the start of the consultation to the end to the nearest minute 
minus the time spent completing the online questionnaire as 
recorded by the web server hosting the iQuit intervention.
2. Patients’ receipt of cessation support at their initial consultation 
in the 8-week follow-up questionnaire. Patients indicated (yes/
no) whether they were invited to set a quit date, had their CO 
measured, were asked about current smoking behavior, asked 
about previous quit attempts, received information on pharma-
cotherapies and received advice on how to quit smoking.
3. Patient satisfaction with the initial consultation was also assessed 
in the 8-week questionnaire. This included three items using a 
five-point scale (1 = not at all, 5 = extremely): how clear they 
found the advice received on pharmacotherapies, the usefulness 
of cessation advice received and satisfaction with the consulta-
tion as a whole, one item on their satisfaction with the amount 
of time spent talking during the consultation (not enough, about 
right, too much) and a final item on whether they felt there was 
something missing from the consultation (yes/no).
4. Type of pharmacotherapy prescribed for each patient, recorded 
by the SCA using the study case report form.
5. The date of every interim contact with the patient and whether 
the contact was by phone or clinic appointment, recorded by the 
SCA up until the 4-week follow-up.
Analysis
The sample size for the trial (n  =  300 per group) assuming a 
power more than 80% and an α < 0.05 (two-sided test) was suffi-
cient to detect a 10% increase in the primary abstinence outcome 
(from 20% to 30%) between trial arms.11 Approximately the 
same power was provided to determine the impact of SCA type 
on the primary outcome measure for the same effect size. Intra-
cluster correlation coefficients were calculated to assess whether 
patients from the same practice had more similar outcomes with 
patients in different practices. Intra cluster correlation coeffi-
cients were low (abstinence at 8 weeks < 0.0001, abstinence at 4 
weeks = 0.02, abstinence at 6 months < 0.0001), therefore, adjust-
ment for clustering was not undertaken in the analysis. However, 
the potential impact of clustering was assessed as part of a sen-
sitivity analysis.
Patients supported by HCAs were compared with those sup-
ported by nurses for each of the outcome measures described. For 
smoking outcomes, logistic regression models were used. Adjusted 
logistic regression models were run for each smoking outcome adjust-
ing for iQIP trial arm and potential confounders that were unbal-
anced between the two groups of patients (patient’s occupational 
category and initial CO reading). A likelihood ratio test was carried 
out comparing the adjusted model with and without SCA type as 
a predictor to assess whether SCA type significantly increased the 
adjusted model’s predictive ability. In addition, an interaction term 
of SCA type by iQIP trial arm was entered into the adjusted models 
to check whether the effect of SCA type on abstinence may have been 
different for those in the two trial arms. Smoking outcome analyses 
were intention-to-treat, where all those randomized were analyzed 
with participants lost to follow-up assumed to be still smoking.
Nurses and HCAs were compared on patient consultation time 
using a t-test and the number of interim contacts using Mann–
Whitney U tests due to a nonnormal distribution. Logistic regression 
was used to compare nurses and HCAs on patients’ recalled receipt of 
support, types of pharmacotherapy prescribed and patient satisfaction 
with the consultation (split into those scoring 4 or 5 on the 5-point 
scales or giving a positive response for the other two items vs. the rest).
Results
Recruitment, Baseline Characteristics and Attrition
There were 313 participants who saw a HCA at their initial appoint-
ment and 289 participants who saw a nurse (N = 602). Participants 
had a mean age of 42 years (SD = 13) at baseline and 53% were 
female. Two-thirds smoked within 30 minutes of waking (Table 1). 
Two participants withdrew from the study. Attrition (noncumula-
tive), defined as not obtaining smoking status or a completed ques-
tionnaire by post or over the telephone, was 30% (4 weeks), 16% 
(8 weeks), and 22% (6 months). As Table 1 shows, patients seen by 
HCAs had similar baseline characteristics to those seen by nurses. 
The only statistically significant difference was the mean level of CO 
in exhaled breath and, although this was higher in the HCA group by 
2.9 parts per million, this was not considered clinically meaningful.15
Smoking Outcomes
There were no statistically significant differences between HCAs com-
pared with nurses in the primary outcome measure of 2-week point 
prevalence abstinence at 8 weeks follow-up in both the unadjusted 
(OR = 1.0, 95% CI = 0.7 to 1.4) and adjusted models (OR = 1.1, 
95% CI = 0.8 to 1.5). Moreover, there were no statistically signif-
icant differences in abstinence at 4 weeks and 6  months between 
patients who saw HCAs and those who saw nurses (Table 2). There 
was no interaction between SCA type and intervention group, that is, 
whether patients saw an HCA or nurse did not modify the effect of 
the iQIP intervention. No differences were observed when analyses 
were further adjusted for clustering at the GP practice level.
Support Provided in the Initial Consultation
HCAs took on average 3 minutes longer than nurses for the consul-
tation (nurses = 21 minutes, HCAs = 24 minutes, P = .002; Table 3). 
The content of the consultation was very similar for both SCA types. 
Over 95% of patients for both HCAs and nurses reported that their 
SCA invited them to set a quit date (HCA 96%, nurses 96%), meas-
ured CO levels (HCAs 96%, nurses 98%) and asked about current 
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smoking (HCAs 97%, nurses 98%). High proportions of patients 
(over 85% in both groups) were also given information on pharma-
cotherapies, asked about previous attempts and given advice on how 
to quit smoking. There were no statistically significant differences 
between HCAs and nurses in any of the above elements of support 
provided in the initial smoking cessation consultation.
There were also no significant differences in prescribing pat-
terns for any of the pharmacotherapies provided to the patients. 
Patients were just as likely to be prescribed two forms of nicotine 
replacement therapy when seen by HCAs as nurses (OR = 0.9, 95% 
CI = 0.6 to 1.2) and for the prescription to be Varenicline (OR = 1.2, 
95% CI = 0.9 to 1.7) or Bupropion (OR = 0.7, 95% CI = 0.2 to 2.8).
Patient Satisfaction With Support Provided
Patients who saw either type of SCA gave positive evaluations of 
the support they received. Ninety-three percent of patients who 
saw HCAs and 91% who saw nurses said they were happy or 
extremely happy with the consultations, and 90% and 85% of 
patients who saw HCAs and nurses respectively reported finding 
the advice they received useful or extremely useful. There were no 
statistically significant differences in any aspect of patient satisfac-
tion by SCA type.
Ongoing Support Provided
Patients who saw HCAs were as likely to have interim contact fol-
lowing the initial consultation compared with patients who saw 
nurses (HCAs 84%, nurses 78%; OR = 1.5, 95% CI = 1.0 to 2.2; 
Table  3). However, HCAs were more likely to have a larger total 
number of contact occasions with their patients overall (median 
number of contacts = 2 for HCAs, 1 for nurses; P < .001) and these 
contacts were more often clinic appointments (HCAs 91%, nurses 
71%; OR = 4.2, 95% CI = 2.9 to 6.3) than phone calls.
Table 1. Baseline Characteristics
HCA (n = 313)a Nurse (n = 289)a Total (n = 602)a P
Female 170 (54.3%) 147 (50.9%) 317 (52.7%) .39
Mean (SD) age 42.3 (13.4) 41.2 (12.5) 41.8 (13.0) .26
White ethnic group 306 (97.8%) 284 (98.3%) 590 (98.0%) .70
Occupational category
 Not working (student/home  
 carer/retired/sick disabled)
88 (28.1%) 52 (18.0%) 140 (23.3%)b .06
 Never worked/long term unemployed 25 (8.0%) 15 (5.2%) 40 (6.6%)
 Routine and manual 94 (30.0%) 88 (30.4%) 182 (30.2%)
 Intermediate 24 (7.7%) 27 (9.3%) 51 (8.5%)
 Managerial/professional 76 (24.3%) 80 (27.7%) 156 (25.9%)
Median (IQ range) number of cigarettes  
 smoked per day
20 (14, 20) 18 (15, 20) 18.5 (14, 20) .81
Patients who smoked first cigarette within 30 minutes  
 of waking
217 (69.3%) 192 (66.4%) 409 (67.9%) .13
Mean (SD) carbon monoxide in exhaled air (parts per  
 million)
22.5 (12.0) 19.6 (12.0) 21.0 (12.1) .007
Motivation to quit (answering extremely or very much 
 to “How much do you want to quit?”)
297 (94.9%) 274 (94.8%) 571 (94.9%) .96
Previously quit smoking for 3 months or longer 177 (56.5%) 166 (57.4%) 343 (57.0%) .83
Median (IQ range) practice list size of SCA 10 314 (8607, 11 981) 10 141 (9177, 11 959) 10 296 (9177, 11 959) .26
Median (IQ range) practice Index of Multiple  
 Deprivation (IMD) score
11.4 (9.2, 15.2) 13.3 (8.6, 20.0) 11.2 (9.2, 16.9) .50
Patients in the trial intervention arm 155 (49.5%) 144 (49.8%) 299 (49.7%) .94
SCA = smoking cessation advisor.
aPercentages may not add up to 100 due to rounding.
bP value for the comparison between groups on occupational category (single variable).
Table 2. Smoking Outcomes Applying the Intention to Treat Principle by Smoking Cessation Advisor (SCA) Seen
HCA,  
n = 313
Nurse, 
n = 289
Unadjusted odds 
ratio (95% CIs)
Adjusted odds  
ratio (95% CI)a
Primary outcome
 Self-reported 2-week point prevalence  
 abstinence at 8-week follow-up
134 (42.8%) 123 (42.6%) 1.01 (0.73–1.40) 1.07 (0.76–1.51); P = .68b
Secondary outcomes
 CO-verified 2-week point prevalence  
 abstinence at 4-week follow-up after quit date
83 (26.5%) 69 (23.9%) 1.15 (0.80–1.66) 1.26 (0.86–1.87); P = .23b
 Self-reported 6-month prolonged abstinence  
 at 6-month follow-up
35 (11.2%) 37 (12.8%) 0.86 (0.52–1.40) 0.93 (0.55–1.56); P = .78b
CI = confidence interval; CO = carbon monoxide.
aAdjusted for patients’ occupational category, initial CO reading and trial intervention arm.
bLikelihood ratio test comparing the adjusted model with and without SCA as a predictor.
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Discussion
This study found that HCAs are equally effective as nurses in support-
ing smoking cessation quit attempts, as indicated by smoking cessation 
outcomes across multiple timepoints. In addition, the content of the 
support delivered including medication provision and as reported by 
the patients, did not differ by healthcare staff type. While HCAs took 
more time to deliver the initial consultation and were more likely to 
provide a greater number of interim contacts and for these contacts to 
be clinic rather than phone appointments, patients were equally satis-
fied with the support they received. Strengths of this study include the 
use of a range of clinically relevant process measures, inclusion of the 
patients’ perspective and use of abstinence outcomes collected across 
multiple timepoints including the use of biochemical verification.
Our findings are in contrast to Hiscock et al.8 who found that 
HCAs had a higher success rate than nurses. One limitation with 
Hiscock et al’s study is that the majority of support episodes logged 
in the Quit Manager database they used for analysis did not have 
a healthcare staff type indicated (57 282 unknown type vs. 5604 
HCAs and 13 095 nurses). Therefore, it is possible that a nonre-
porting bias could have influenced the results. Our findings are in 
line with Katz et al. who found no differences in the performance 
of smoking cessation activities carried out by different primary 
care professional grades. Our study shows not only that HCAs car-
ried out the same basic content in smoking cessation interventions 
according to patients but patient satisfaction was equally high.
These findings of broad equivalence between the two types of 
community SCA supports increasing the opportunities for HCAs to 
become trained in this role. This could have several advantages. It 
could reduce waiting times by increasing availability and enable nurses 
to concentrate on patients with complex clinical needs, long-term con-
ditions, and preventative work. These effects have been shown to take 
place on the introduction of HCAs into primary care skill mix.16–19
Qualitative studies have pointed to a value laden hierarchy in 
primary care where GPs and nurses have described the HCA role as 
“routine,” “menial,” “basic,” “straightforward,” and “lower-end”20 
and with HCAs themselves referring to their tasks as “menial,” 
“silly,” and “mundane.”16 Training HCAs to undertake smoking ces-
sation treatments may increase job satisfaction and in turn increase 
employee retention, although this remains speculative.
HCAs were found to use more time to deliver support than nurses 
for no observed improvement in cessation outcomes. To determine 
whether HCAs deliver more cost-effective support than nurses, this 
additional time cost would need to be offset by their lower staff costs. 
In addition, how the released time of nurses might be put to use should 
also be taken into account, that is, the higher the value of the task that 
the nurse performs instead of delivering smoking cessation treatments, 
the more cost effective the substitution would be.21
This study has several limitations. While the 4-week smoking out-
come was biochemically verified using a CO breath test, the 8-week 
and 6-month outcomes were self-report only. Ideally participants 
would be followed up beyond 6 months and have their abstinence bio-
chemically verified, although for this study it was not considered feasi-
ble. In addition, receipt of cessation support provided and satisfaction 
with the initial consultation was collected from patients 8 weeks after 
the initial consultation potentially increasing the risk of recall bias.22
Although randomization was stratified by SCA, resulting in 
roughly equal numbers of participants assigned to nurses and HCAs, 
Table 3. Smoking Cessation Support Provided by Smoking Cessation Advisor (SCA)
Patients seen by  
HCA (n = 313)
Patients seen by  
nurse (n = 289)
Odds ratio  
(95% CIs)/P value
Time taken for initial consultation (SD) minutesa 23.6 (11.9) 20.8 (9.8) .002
Patients’ recollections of SCA behavior in the initial consultationb
 Invited to set a quit date 212 (96.4%) 209 (96.3%) 1.01 (0.37–2.75)
 Gave information on pharmacotherapies 198 (90.0%) 195 (89.9%) 1.01 (0.54–1.89)
 Measured CO levels 212 (96.4%) 212 (97.7%) 0.63 (0.20–1.94)
 Asked about current smoking behavior 213 (96.8%) 212 (97.7%) 0.72 (0.22–2.30)
 Asked about previous attempts 204 (92.7%) 198 (92.1%) 1.22 (0.61–2.44)
 Given advice on how to quit smoking 198 (90.0%) 189 (87.1%) 1.33 (0.74–2.41)
Prescribing patterns
 Prescribed at least one NRT 162 (51.8%) 163 (56.4%) 0.83 (0.60–1.14)
 Prescribed two forms of NRT 76 (24.3%) 79 (27.3%) 0.85 (0.59–1.23)
 Prescribed Varenicline 138(44.1%) 115 (39.8%) 1.19 (0.86–1.65)
 Prescribed Bupropion 4 (1.3%) 5 (1.7%) 0.73 (0.20–2.77)
Patient satisfaction with supportc
 Found advice on pharmacotherapy and NRT clear or extremely clear 188/217 (86.7%) 188/216 (87.0%) 0.98 (0.55–1.69)
 Found advice useful or extremely useful 197/220 (89.5%) 180/213 (84.5%) 1.57 (0.88–2.77)
 Were happy or extremely happy with the consultation 204/219 (93.2%) 196/215 (91.2%) 1.32 (0.65–2.67)
 Thought the amount of time spent talking was about right 201/217 (92.6%) 195/213 (91.5%) 1.15 (0.57–2.34)
 Felt that there was not anything missing from the consultation 201/219 (91.8%) 194/211 (91.9%) 0.98 (0.49–1.95)
Interim contacts
 Had any interim contact 262 (83.7%) 225 (77.9%) 1.46 (0.97–2.20)
 Interim contact was clinic rather than phoned 455/499 contacts (91.2%) 232/327 contacts (70.9%) 4.23 (2.86–6.26)
 Median (IQ range) number of contacts 2 (1, 3) 1 (0, 2) <.001
CI = confidence interval; CO = carbon monoxide; HCA = healthcare assistant; NRT = nicotine replacement therapy.
aThere were times missing for 24 patients (patients seen by HCAs = 297, nurses = 281).
bCollected at the 8-week follow-up (patients seen by HCAs = 220, nurses = 217).
cThe denominator for each question varied as indicated.
dFor 63 participants, the type of contact was not recorded (patients seen by HCAs = 279, nurses = 260).
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the type of SCA seen by participants was not determined at random. 
While the participants in each SCA group had similar characteristics, 
it is possible that there were unmeasured confounders, such as a high 
number of other smokers in a participant’s environment23 or high 
levels of negative affect.24 There may also have been unmeasured 
SCA characteristics that were confounders, such as experience in 
delivering cessation support,25 training received,26 role satisfaction,9 
and personal ability to build rapport.27
In terms of representativeness, the index of multiple deprivation 
scores for the practices that participated in the trial showed that only 
8 of the 32 practices were in the highest 50% of deprived small geo-
graphical areas for England (lower super output areas). Therefore, 
there were fewer practices in areas of deprivation than would be 
expected for a representative sample taken from across England. The 
relatively low participation rate among practices approached (31%) 
could have contributed to this issue and could have reduced sample 
representativeness overall if there were differences in the characteris-
tics of practices participating and those not. Analysis of the study par-
ticipants showed that they were generally similar in characteristics to 
the Stop Smoking Service nationally28 though there were higher rates 
of employment (iQIP 65%; national 43%) and people classifying 
themselves as from a white ethnic group (iQIP 98%; national 88%).
Conclusion
HCAs appear to be equally as effective as nurses in supporting 
smoking cessation quit attempts, though they do this with more 
patient contact. Increasing skill mix in the area of smoking cessation 
in primary care could potentially save nurse time and costs, improve 
patient access and provide enhanced services without compromising 
outcomes. Further studies looking at the knock-on effects of HCAs 
providing a larger proportion of smoking cessation consultations in 
primary care would help determine this.
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